newsfilter
← Latest News
GlobeNewswire·

NextCure Provides Business Update and Reports Second Quarter 2025 Financial Results

Announced strategic partnership with Simcere Zaiming for Phase 1 program SIM0505 (CDH6 ADC) with plans to dose the first SIM0505 patient in the United States this quarter Currently in cohort 4 of the Phase 1 trial of